Global Infectious Diseases Diagnostics Market Size Study, by Product & Service (Assays, Kits, Reagents, Instruments, Services & Software) by Technology (Immunodiagnostics, Clinic Microbiology, DNA Microarray) by Disease Type (Tuberculosis, HAIS, HIV, Hepatitis) by End Use (Hospital, Physician Offices, Others) by Regional Forecasts 2017-2025

April 2018 | 120 pages | ID: G82C89AA1FFEN
Bizwit Research & Consulting LLP

Abstracts

Global Infectious Diseases Diagnostics Market valued approximately USD 14 billion in 2016 is anticipated to grow with a healthy growth rate of more than 6 % over the forecast period 2017-2025. Growing prevalence of infectious diseases across the globe, increasing funding for research for infectious disease diagnostics and the change in focus from centralized laboratories to decentralized point-of-care testing. Infectious disease diagnostics are several techniques used by professionals to diagnose and detect pathogens in human samples such as throat swab, urine, serum, blood, and stool.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product & Service:

• Assays, Kits, Reagents
• Instruments
• Services & Software

By Technology:

• Immunodiagnostics
• Clinic Microbiology
• Polymerase Chain Reaction (PCR)
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• DNA Sequencing & Next-Generation Sequencing
• DNA Microarray
• Other Technologies

By Diseases Type:

• Hepatitis
• Hepatitis Diagnostics Market
• Human Immunodeficiency Virus (HIV)
• Chlamydia Trachomatis Genital Infection & Gonorrhea
• Hospital-Acquired Infection (HAIS)
• Tuberculosis
• Tuberculosis Diagnostic Market
• Influenza
• Influenza Diagnostics Market
• Other Infectious Diseases

By End-Use:

• Hospitals/Clinical Laboratories
• Reference Laboratories
• Physician Offices
• Academic/Research Institutes
• Others

By Regions:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• China
• India
• Japan
• Latin America
• Brazil
• Mexico
• Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025

Some of the key manufacturers involved in the market Abbott Laboratories, Becton, Dickinson & Company, Danaher Corporation, Bio-Rad Laboratories, Diasorin, Luminex, Meridian Bioscience, Quidel, Roche Diagnostics, Siemens AG. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the Global Infectious Diseases Diagnostics Market in Market Study:

• Key Consulting Companies & Advisors
• Large, medium-sized, and small enterprises
• Venture capitalists
• Value-Added Resellers (VARs)
• Third-party knowledge providers
• Investment bankers
• Investors

Contents

CHAPTER 1. GLOBAL INFECTIOUS DISEASES DIAGNOSTICS MARKET DEFINITION AND SCOPE

1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation

CHAPTER 2. RESEARCH METHODOLOGY

2.1. Research Process
  2.1.1. Data Mining
  2.1.2. Analysis
  2.1.3. Market Estimation
  2.1.4. Validation
  2.1.5. Publishing
2.2. Research Assumption

CHAPTER 3. EXECUTIVE SUMMARY

3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends

CHAPTER 4. GLOBAL INFECTIOUS DISEASES DIAGNOSTICS MARKET DYNAMICS

4.1. Growth Prospects
  4.1.1. Drivers
  4.1.2. Restraints
  4.1.3. Opportunities
4.2. Industry Analysis
  4.2.1. Porter’s 5 Force Model
  4.2.2. PEST Analysis
  4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion

CHAPTER 5. GLOBAL INFECTIOUS DISEASES DIAGNOSTICS MARKET, BY PRODUCT & SERVICE

5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Global Infectious Diseases Diagnostics Market, Sub Segment Analysis
  5.3.1. Assays, Kits, Reagents
    5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.2. Instruments
    5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.3. Services & Software
    5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 6. GLOBAL INFECTIOUS DISEASES DIAGNOSTICS MARKET, BY TECHNOLOGY

6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Global Infectious Diseases Diagnostics Market, Sub Segment Analysis
  6.3.1. Immunodiagnostics
    6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.3.2. Clinic Microbiology
    6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.3.3. Polymerase Chain Reaction (PCR)
    6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.3.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
    6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.3.5. DNA Sequencing & Next-Generation Sequencing
    6.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.3.6. DNA Microarray
    6.3.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.3.7. Other technologies
    6.3.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 7. GLOBAL INFECTIOUS DISEASES DIAGNOSTICS MARKET, BY DISEASE TYPE

7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Global Infectious Diseases Diagnostics Market, Sub Segment Analysis
  7.3.1. Hepatitis
    7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    7.3.1.3. Hepatitis Sub Segments breakdown estimates & forecasts, 2015-2025 (USD Billion)
      7.3.1.3.1. Hepatitis Diagnostics Market
  7.3.2. Human Immunodeficiency Virus (HIV)
    7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.3.3. Chlamydia Trachomatis Genital Infection & Gonorrhoea (CT/NG)
    7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.3.4. Hospital-Acquired Infection (HAIS)
    7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.3.5. Tuberculosis
    7.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    7.3.5.3. Tuberculosis (TB) Sub Segment breakdown estimates & forecast, 2015-2025 (USD Billion)
      7.3.5.3.1. Tuberculosis Diagnostic Market.
  7.3.6. Influenza
    7.3.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    7.3.6.3. Influenza Sub Segment breakdown estimates & forecasts, 2015-2025 (USD Billion)
      7.3.6.3.1. Influenza Diagnostics Market.
  7.3.7. Other Infectious Diseases
    7.3.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 8. GLOBAL INFECTIOUS DISEASES DIAGNOSTICS MARKET, BY END-USE

8.1. Market Snapshot
8.2. Market Performance - Potential Model
8.3. Global Infectious Diseases Diagnostics Market, Sub Segment Analysis
  8.3.1. Hospital/Clinical Laboratories
    8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.2. Reference Laboratories
    8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.3. Physician Offices
    8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.4. Academic/ Research Institutes
    8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.5. Other End Use.
    8.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 9. GLOBAL INFECTIOUS DISEASES DIAGNOSTICS MARKET, BY REGIONAL ANALYSIS

9.1. Infectious Diseases Diagnostics Market, Regional Market Snapshot (2015-2025)
9.2. North America Infectious Diseases Diagnostics Market Snapshot
  9.2.1. U.S.
    9.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.2.1.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.2.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.2.1.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.2.1.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.2.2. Canada
    9.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.2.2.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.2.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.2.2.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.2.2.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3. Europe Infectious Diseases Diagnostics Market Snapshot
  9.3.1. U.K.
    9.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.3.1.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.1.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.1.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.3.2. Germany
    9.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.3.2.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.2.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.2.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.3.3. France
    9.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.3.3.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.3.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.3.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.3.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.3.4. Rest of Europe
    9.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.3.4.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.4.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.4.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.3.4.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4. Asia Infectious Diseases Diagnostics Market Snapshot
  9.4.1. China
    9.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.4.1.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.1.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.1.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.4.2. India
    9.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.4.2.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.2.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.2.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.4.3. Japan
    9.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.4.3.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.3.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.3.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.3.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.4.4. Rest of Asia Pacific
    9.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.4.4.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.4.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.4.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.4.4.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5. Latin America Infectious Diseases Diagnostics Market Snapshot
  9.5.1. Brazil
    9.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.5.1.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.5.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.5.1.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.5.1.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.5.2. Mexico
    9.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.5.2.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.5.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.5.2.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.5.2.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6. Rest of The World
  9.6.1. South America
    9.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.6.1.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.6.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.6.1.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.6.1.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
  9.6.2. Middle East and Africa
    9.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    9.6.2.2. Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.6.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.6.2.4. Disease Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    9.6.2.5. End Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 10. COMPETITIVE INTELLIGENCE

10.1. Company Market Share (Subject to Data Availability)
10.2. Top Market Strategies
10.3. Company Profiles
  10.3.1. Abbott Laboratories
    10.3.1.1. Overview
    10.3.1.2. Financial (Subject to Data Availability)
    10.3.1.3. Product Summary
    10.3.1.4. Recent Developments
  10.3.2. Becton, Dickinson & Company
  10.3.3. Bio-Rad Laboratories
  10.3.4. Danaher Corporation
  10.3.5. Diasorin
  10.3.6. Luminex
  10.3.7. Meridian Bioscience
  10.3.8. Quidel
  10.3.9. Roche Diagnostics
  10.3.10. Siemens AG